Literature DB >> 11832994

Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15.

H Rothe1, A Hausmann, H Kolb.   

Abstract

Non-obese diabetic (NOD) mice spontaneously develop insulin dependent diabetes due to autoimmune destruction of beta-cells. The progression of insulitis can be accelerated and synchronized in the pancreas by a single injection of 250 mg/kg cyclophosphamide. In this study, we will report on three immune mediators that were not known to be expressed during insulitis until now. Early insulitis in ten-week-old female NOD mice was associated with strong expression of prostaglandin H synthase 2 in the pancreas and of arginase, an antagonist enzyme of the inducible NO synthase. After acceleration of insulitis progression by cyclophosphamide, expression of the two enzymes was downregulated within 24 h. There was strong concomitant upregulation of IL-15 gene expression that preceded lymphocyte invasion of islets and a rise of IFN-gamma mRNA levels by several days. The comparison of individual pancreata showed that the expression of IL-12 and IL-18 mRNA closely correlated with levels of IL-15 gene expression. We conclude that arginase and prostaglandin H synthase 2 expression is associated with peri-insulitis, while IL-15 is a candidate cytokine in driving destructive insulitis, as it elicits Th1-cytotoxic responses in lymphoid as well as in non-lymphoid immune cells and is unusually resistant to downregulation by antagonistic cytokines. This is the first report on arginase, prostaglandin H synthase 2 and IL-15 expression in pancreatic lesions of prediabetic NOD mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832994     DOI: 10.1055/s-2002-19959

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

2.  Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.

Authors:  D Bobbala; X-L Chen; C Leblanc; M Mayhue; J Stankova; T Tanaka; Y-G Chen; S Ilangumaran; S Ramanathan
Journal:  Diabetologia       Date:  2012-08-14       Impact factor: 10.122

3.  Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development.

Authors:  Katarzyna Siewko; Rafal Maciulewski; Anna Zielinska-Maciulewska; Anna Poplawska-Kita; Piotr Szumowski; Natalia Wawrusiewicz-Kurylonek; Danuta Lipinska; Robert Milewski; Maria Gorska; Adam Kretowski; Malgorzata Szelachowska
Journal:  Biomed Res Int       Date:  2019-10-20       Impact factor: 3.411

4.  Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof.

Authors:  Enrique Z Fisman; Michael Motro; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2003-09-12       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.